NCM
CRBU icon

Next Capital Management’s Caribou Biosciences CRBU Stock Holding History

Next Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.2K Hold
20,000
– – 0.01% 137
2026
Q1 		$38K Hold
20,000
– – 0.01% 133
2025
Q4 		$31.8K Hold
20,000
– – 0.01% 134
2025
Q3 		$46.6K Hold
20,000
– – 0.02% 135
2025
Q2 		$25.2K Buy
+20,000
New +$19.7K 0.01% 135

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Next Capital Management's CRBU Position: Q2 2026 in Review

Next Capital Management held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 20,000 shares worth $35.2K. The position accounts for 0.01% of the portfolio, ranked #137.

Next Capital Management first reported a position in CRBU in Q2 2025 and has held it in 5 quarters since. The position peaked at $46.6K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Next Capital Management held 20,000 shares of Caribou Biosciences worth $35.2K as of Q2 2026.
  • Next Capital Management left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up 0.01% of Next Capital Management's portfolio in Q2 2026, its #137 holding.
  • Next Capital Management first reported a position in Caribou Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Next Capital Management's Caribou Biosciences position peaked at $46.6K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Next Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.